Most Recent

image: In the Long Run

In the Long Run

By Mary Beth Aberlin | December 1, 2012

Can emulating our early human ancestors make us healthier?

1 Comment

image: Long and Rocky Roads

Long and Rocky Roads

By Mary Beth Aberlin | November 1, 2012

From basic research to beneficial therapies

0 Comments

image: Mission: Possible

Mission: Possible

By Mary Beth Aberlin | October 1, 2012

Cooperation, not competition, is the way forward.

1 Comment

image: Meeting of the Minds

Meeting of the Minds

By Mary Beth Aberlin | July 1, 2012

New changes at The Scientist will ensure that we continue to showcase the best and brightest ideas in the life sciences.

1 Comment

image: Agents Provocateurs

Agents Provocateurs

By Mary Beth Aberlin | April 1, 2012

Asking pointed questions is a key part of the scientific process.

3 Comments

image: Tricky Trials

Tricky Trials

By Mary Beth Aberlin | March 1, 2012

Studies on safety, efficacy, or dosing of drugs in children, or on nutritional supplements, are not run-of-the-mill.

0 Comments

A Truly Happy Return

By Mary Beth Aberlin | December 1, 2011

After a roller-coaster of an October, The Scientist resumes publication under new ownership.

12 Comments

. . . And Many Happy Returns

By Mary Beth Aberlin | October 1, 2011

To the great scientific leaps witnessed during our first 25 years, and the game changers yet to come.

0 Comments

image: Hold That Thought

Hold That Thought

By Mary Beth Aberlin | September 1, 2011

In the memory circuits of the aging brain and the signaling pathways of pain, science is trading mystery for mastery.

15 Comments

image: The “Me Decade” of Cancer

The “Me Decade” of Cancer

By Sarah Greene | April 1, 2011

Drugs that target specific tumors are harbingers of a new era of genetically informed medicine.

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Probiotics Prevent Cholera in Animal Models